Finally, the protective missense variant in AR, which encodes the androgen receptor, is notable given the widespread treatment of prostate cancer patients with anti-androgen therapies37, and highlights the connection between rare germline variant disease associations and potential therapeutic targets. This evidence concerns the gene AR and prostate cancer.